Treatment of tuberculosis in developing countries. | Lancet;346(8982): 1098-9, 1995 Oct 21. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Subject descriptor lookup Advanced Search EVID@Easy

Treatment of tuberculosis in developing countries.

Elliott, A M; Mwinga, A G; Foster, S D.

Lancet ; 346(8982): 1098-9, 1995 Oct 21.

Article in En | MEDLINE | ID: mdl-7564805

Subject(s)

Antitubercular Agents/adverse effects; Developing Countries; HIV Seropositivity/complications; Thioacetazone/adverse effects; Tuberculosis/drug therapy; Antitubercular Agents/therapeutic use; Drug Therapy, Combination; HIV Seroprevalence; Humans; Infant; Tanzania; Zambia

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Thioacetazone / Tuberculosis / HIV Seropositivity / Developing Countries / Antitubercular Agents Aspects: Determinantes_sociais_saude Limits: Humans / Infant Country/Region as subject: Africa Language: En Journal: Lancet Year: 1995 Document type: Article Country of publication: United kingdom

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Thioacetazone / Tuberculosis / HIV Seropositivity / Developing Countries / Antitubercular Agents Aspects: Determinantes_sociais_saude Limits: Humans / Infant Country/Region as subject: Africa Language: En Journal: Lancet Year: 1995 Document type: Article Country of publication: United kingdom